ArticleCureus2023
Primary Rifampicin Mono-Resistant Extrapulmonary Tuberculosis Presenting as a Posterior Chest Wall Abscess: The World's First Case.
Article in Cureus, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed, 0 citations in OpenAlex.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Extrapulmonary tuberculosis is a relatively infrequent occurrence. Tubercular involvement of the chest wall is rare. There has never been a record of an isolated primary rifampicin mono-resistant extrapulmonary tuberculosis presenting as a posterior chest wall abscess in the medical literature, making such cases extremely uncommon. In this case report, a 17-year-old Indian male is presented who reported chief complaints of a painless swelling in the posterior chest wall. A comprehensive lab workup ultimately resulted in a conclusive diagnosis. Following the national guidelines, the patient was started on an anti-tubercular treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.